Expert Review of Neurotherapeutics, 1744-8360

Journal

More filtering options
  1. 2015
  2. Dopamine and Huntington's disease

    Schwab, L. C., Garas, S. N., Garas, S. N., Drouin-Ouellet, J., Mason, S. L., Stott, S. R. & Barker, R. A., 2015 Apr, In : Expert Review of Neurotherapeutics. 15, 4, p. 445-58 14 p.

    Research output: Contribution to journalArticle

  3. 2013
  4. Health economic evaluation: why? When? How?

    Kobelt, G., 2013, In : Expert Review of Neurotherapeutics. 13, 12, p. 33-37

    Research output: Contribution to journalReview article

  5. 2011
  6. Can alpha-synuclein be targeted in novel therapies for Parkinson's disease?

    Brundin, P. & Roger Olsson, 2011, In : Expert Review of Neurotherapeutics. 11, 7, p. 917-919

    Research output: Contribution to journalArticle

  7. 2005
  8. Interferon-beta1a treatment for multiple sclerosis.

    Sandberg Wollheim, M., 2005, In : Expert Review of Neurotherapeutics. 5, 1, p. 25-34

    Research output: Contribution to journalArticle